July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Kuwait oil price down to USD 88.46 pb

The price of Kuwaiti oil went down 43 cents to reach USD 88.46 per barrel on Wednesday as opposed to USD 88.89 last Tuesday, said the Kuwait Petroleum Corporation (KPC) on Thursday.

On a global scale, the price of the Brent crude futures’ contracts w…

Arabic influence on Turkish.. A linguistic, cultural legacy

Once entering Turkiye, Arabic-speaking visitors would be greeted with words that sound very familiar ” Merhaba, hosgeldiniz ” meaning ” hello , welcome” with every interaction with the locals, the words seem familiar yet pronounced differently.

This …

Israeli warplanes raid house in S. Lebanon, kills one person

Israeli occupation warplanes on Thursday raided a house in the southern village of Hola, killing one person, the official National News Agency said.

They also attacked the village of Aitaroun, while gunners hit the town of Al-Khiam, outskirts of Al-N…